THERAPEUTIC TARGETING OF TUMOR-ASSOCIATED MACROPHAGES WITH ANTI-CD163 NANOBODY-DRUG CONJUGATES AS NOVEL CANCER THERAPY

Research output: Unpublished contribution to conferencePoster

Abstract


Original languageEnglish
Publication statusPublished - 21 May 2024
EventPoster session presented at 17TH ENII EFIS EJI SUMMER SCHOOL ON ADVANCED IMMUNOLOGY, Alghero, Italy.
-
Duration: 17 Sep 202424 Sep 2024

Conference

ConferencePoster session presented at 17TH ENII EFIS EJI SUMMER SCHOOL ON ADVANCED IMMUNOLOGY, Alghero, Italy.
Period17/09/2424/09/24

Keywords

  • Cancer Immunotherapy
  • Nanobodies
  • CD163

Cite this